Radiotherapy, Temozolomide and Bevacizumab followed by Irinotecan, Temozolomide and Bevacizumab Appears Well-tolerated and Efficacious in Newly Diagnosed Glioblastoma Multiforme: Results from a Phase II Trial


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Kirkpatrick, JP; Desjardins, A; Reardon, DA; Friedman, AH; Friedman, HS; Vredenburgh, JJ

Published Date

  • November 2009

Published In

Volume / Issue

  • 75 / 3

Start / End Page

  • S102 - S103

Published By

International Standard Serial Number (ISSN)

  • 0360-3016

Digital Object Identifier (DOI)

  • 10.1016/j.ijrobp.2009.07.250